Table 2 Perioperative patients information.
Characteristics | Endoscope (%) | Microscope (%) | t/ χ2/Z | P | |||
|---|---|---|---|---|---|---|---|
Efficacy | 6.500 | 0.039* | |||||
Effective | |||||||
Healed Mitigation Invalid | 59(93.7) 4(6.3) 0(0) | 60(81.1) 8(10.8) 6(8.1) | |||||
Recurrence Operative time (mins) Hospitalization time (days) | 3(4.8) 192.62 ± 7.38 7.73 ± 0.30 | 8(10.8) 186.43 ± 5.39 8.08 ± 0.38 | 0.246 0.285 0.102 | 0.620 0.776 0.919 | |||
Responsible vessels | 4.399 | 0.883 | |||||
SCA AICA PICA VA BA PV SCA + AICA SCA + PICA SCA + PV SCA + BA | 46(73.1) 7(11.1) 1(1.6) 4(6.3) 1(1.6) 1(1.6) 2(3.2) 1(1.6) 0(0) 0(0) | 54(73.0) 6(8.1) 2(2.7) 3(4.1) 2(2.7) 3(4.1) 1(1.4) 1(1.4) 1(1.4) 1(1.4) | |||||
Postoperative complications | 0.243 | 0.622 | |||||
Aseptic meningitis Facial paralysis Intracranial infection Low intracranial pressure syndrome Postoperative intracranial hemorrhage cerebrospinal fluid leakage Hydrocephalus Hearing loss Transient diplopia Cerebellar infarction Death | 3(4.8) 0(0) 0(0) 2(3.2) 0(0) 0(0) 0(0) 1(1.6) 0(0) 0(0) 0(0) | 5(6.8) 1(1.4) 0(0) 1(1.4) 0(0) 2(2.7) 0(0) 0(0) 0(0) 0(0) 0(0) | |||||
